Developing regions vs Saint Kitts and Nevis: Proportion of the target population … measles-containing-vaccine
Developing regions
75.0%
in 2024
Saint Kitts and Nevis
97.0%
in 2024
Developing regions rank
23rd
Saint Kitts and Nevis rank
22nd
Proportion of the target population … measles-containing-vaccine over time
- Developing regions
- Saint Kitts and Nevis
How they compare
Saint Kitts and Nevis currently reports 97.0% against 75.0% in Developing regions, a difference of 22.0%.
That makes Saint Kitts and Nevis's figure about 1.3 times Developing regions's.
Across all 25 years both countries report, Saint Kitts and Nevis has been ahead every year.
Developing regions ranks 23rd and Saint Kitts and Nevis ranks 22nd of 36 groups.
Saint Kitts and Nevis has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Developing regions | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.2% | 97.4% | 74.2% | Saint Kitts and Nevis |
| 2010s | 56.0% | 94.7% | 38.7% | Saint Kitts and Nevis |
| 2020s | 71.0% | 95.4% | 24.4% | Saint Kitts and Nevis |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Developing regions or Saint Kitts and Nevis?
- Saint Kitts and Nevis, at 97.0% against 75.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received between Developing regions and Saint Kitts and Nevis?
- 22.0%, with Saint Kitts and Nevis ahead.
- How many years of comparable data are there for Developing regions and Saint Kitts and Nevis?
- 25 years are reported by both, from 2000 to 2024.
- How do Developing regions and Saint Kitts and Nevis rank globally for proportion of the target population who received?
- Developing regions ranks 23rd and Saint Kitts and Nevis ranks 22nd of 36 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.